Two Sigma Securities’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-28,571
Closed -$36.9K 1641
2024
Q4
$36.9K Buy
+28,571
New +$36.9K ﹤0.01% 1040
2022
Q4
Sell
-13,384
Closed -$22K 1587
2022
Q3
$22K Buy
+13,384
New +$22K ﹤0.01% 1076
2017
Q2
Sell
-15,243
Closed -$35K 974
2017
Q1
$35K Buy
+15,243
New +$35K 0.01% 824
2016
Q4
Sell
-15,429
Closed -$17K 793
2016
Q3
$17K Buy
+15,429
New +$17K 0.01% 611